Trends in Heart Failure Mortality in Sweden Between 1997 and 2022
Heart failure-related mortality has declined over the last ~25 years in Sweden. All-cause mortality in patients with HF has also declined, more in HF with reduced than preserved EF, mirroring the different availability of life-saving treatments across the EF spectrum.
Authors
- Gianluigi Savarese (ORCID: https://orcid.org/0000-0001-7732-0887)
- Lina Benson
- Felix Lindberg (ORCID: https://orcid.org/0000-0002-7380-9877)
- Ulf Dahlström (ORCID: https://orcid.org/0000-0001-6353-8041)
- Lars H. Lund
Institutions
- Linköping University (SE)
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- European Journal of Heart Failure
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1002/ejhf.3506
- Citations
- 25
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 10.05
Funders
- Amgen
- Pfizer
- AstraZeneca
- Boston Scientific Corporation
- Karolinska Institutet
- Vetenskapsrådet
- HjärtLung Uppsala, Länsföreningen